Matches in SemOpenAlex for { <https://semopenalex.org/work/W755613078> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W755613078 endingPage "502" @default.
- W755613078 startingPage "2497" @default.
- W755613078 abstract "CD4(+) T cell counts have been used as the indicator of human immunodeficiency virus type 1 (HIV-1) disease progression and thereby to determine when to start highly active antiretroviral therapy (HAART). Whether and how the baseline CD4(+) T cell count affects the immunological and viral responses or adverse reactions to nevirapine (NVP)-containing HAART in Chinese HIV-1 infected adults remain to be characterized.One hundred and ninety-eight HIV-seropositive antiretroviral therapy (ART)-naive subjects were enrolled into a prospective study from 2005 to 2007. Data were analyzed by groups based on baseline CD4(+) T cell counts either between 100 - 200 cells/microl or 201 - 350 cells/microl. Viral responses, immunologic responses and adverse events were monitored at baseline and at weeks 4, 12, 24, 36, 52, 68, 84, 100.Eighty-six and 112 subjects ranged their CD4(+) T cell counts 100 - 200 cells/microl and 201 - 350 cells/microl, respectively. The pre-HAART viral load in CD4 201 - 350 cells/microl group was significantly lower than that in CD4 100 - 200 cells/microl group (P = 0.000). After treatment, no significant differences were observed between these two groups either in the plasma viral load (pVL) or in the viral response rate calculated as the percentage of pVL less than 50 copies/ml or less than 400 copies/ml. The CD4(+) T cell counts were statistically higher in the 201 - 350 group during the entire follow-ups (P < 0.01) though CD4(+) T cell count increases were similar in these two groups. After 100-week treatment, the median of CD4(+) T cell counts were increased to 331 cells/microl for CD4 100 - 200 cells/microl group and to 462 cells/microl for CD4 201 - 350 cells/microl group. Only a slightly higher incidence of nausea was observed in CD4 201 - 350 cells/microl group (P = 0.05) among all adverse reactions, including rash and liver function abnormality.The pVLs and viral response rates are unlikely to be associated with the baseline CD4(+) T cell counts. Initiating HAART in Chinese HIV-1 infected patients with higher baseline CD4(+) T cell counts could result in higher total CD4(+) T cell counts thereby achieve a better immune recovery. These results support current guidelines to start HAART at a threshold of 350 cells/microl." @default.
- W755613078 created "2016-06-24" @default.
- W755613078 creator A5025546736 @default.
- W755613078 creator A5028609590 @default.
- W755613078 creator A5034318690 @default.
- W755613078 creator A5037849009 @default.
- W755613078 creator A5040440297 @default.
- W755613078 creator A5044459845 @default.
- W755613078 creator A5071269002 @default.
- W755613078 date "2009-10-20" @default.
- W755613078 modified "2023-09-29" @default.
- W755613078 title "Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study." @default.
- W755613078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20079166" @default.
- W755613078 hasPublicationYear "2009" @default.
- W755613078 type Work @default.
- W755613078 sameAs 755613078 @default.
- W755613078 citedByCount "2" @default.
- W755613078 countsByYear W7556130782012 @default.
- W755613078 countsByYear W7556130782022 @default.
- W755613078 crossrefType "journal-article" @default.
- W755613078 hasAuthorship W755613078A5025546736 @default.
- W755613078 hasAuthorship W755613078A5028609590 @default.
- W755613078 hasAuthorship W755613078A5034318690 @default.
- W755613078 hasAuthorship W755613078A5037849009 @default.
- W755613078 hasAuthorship W755613078A5040440297 @default.
- W755613078 hasAuthorship W755613078A5044459845 @default.
- W755613078 hasAuthorship W755613078A5071269002 @default.
- W755613078 hasConcept C126322002 @default.
- W755613078 hasConcept C142462285 @default.
- W755613078 hasConcept C159047783 @default.
- W755613078 hasConcept C188816634 @default.
- W755613078 hasConcept C197934379 @default.
- W755613078 hasConcept C203014093 @default.
- W755613078 hasConcept C2776090121 @default.
- W755613078 hasConcept C2779130552 @default.
- W755613078 hasConcept C2779690655 @default.
- W755613078 hasConcept C2780727368 @default.
- W755613078 hasConcept C2993143319 @default.
- W755613078 hasConcept C3013748606 @default.
- W755613078 hasConcept C71924100 @default.
- W755613078 hasConcept C8891405 @default.
- W755613078 hasConcept C90924648 @default.
- W755613078 hasConceptScore W755613078C126322002 @default.
- W755613078 hasConceptScore W755613078C142462285 @default.
- W755613078 hasConceptScore W755613078C159047783 @default.
- W755613078 hasConceptScore W755613078C188816634 @default.
- W755613078 hasConceptScore W755613078C197934379 @default.
- W755613078 hasConceptScore W755613078C203014093 @default.
- W755613078 hasConceptScore W755613078C2776090121 @default.
- W755613078 hasConceptScore W755613078C2779130552 @default.
- W755613078 hasConceptScore W755613078C2779690655 @default.
- W755613078 hasConceptScore W755613078C2780727368 @default.
- W755613078 hasConceptScore W755613078C2993143319 @default.
- W755613078 hasConceptScore W755613078C3013748606 @default.
- W755613078 hasConceptScore W755613078C71924100 @default.
- W755613078 hasConceptScore W755613078C8891405 @default.
- W755613078 hasConceptScore W755613078C90924648 @default.
- W755613078 hasIssue "20" @default.
- W755613078 hasLocation W7556130781 @default.
- W755613078 hasOpenAccess W755613078 @default.
- W755613078 hasPrimaryLocation W7556130781 @default.
- W755613078 hasRelatedWork W1973136419 @default.
- W755613078 hasRelatedWork W1978739962 @default.
- W755613078 hasRelatedWork W1990260535 @default.
- W755613078 hasRelatedWork W2008382587 @default.
- W755613078 hasRelatedWork W2022649583 @default.
- W755613078 hasRelatedWork W2039716476 @default.
- W755613078 hasRelatedWork W2043235382 @default.
- W755613078 hasRelatedWork W2060901160 @default.
- W755613078 hasRelatedWork W2061261026 @default.
- W755613078 hasRelatedWork W2078320490 @default.
- W755613078 hasRelatedWork W2084236692 @default.
- W755613078 hasRelatedWork W2086310869 @default.
- W755613078 hasRelatedWork W2092539698 @default.
- W755613078 hasRelatedWork W2134124559 @default.
- W755613078 hasRelatedWork W2352412645 @default.
- W755613078 hasRelatedWork W2378505325 @default.
- W755613078 hasRelatedWork W2463093113 @default.
- W755613078 hasRelatedWork W2789522385 @default.
- W755613078 hasRelatedWork W2903709332 @default.
- W755613078 hasRelatedWork W2065988559 @default.
- W755613078 hasVolume "122" @default.
- W755613078 isParatext "false" @default.
- W755613078 isRetracted "false" @default.
- W755613078 magId "755613078" @default.
- W755613078 workType "article" @default.